Improving Bone Density with Hormone Therapy for Osteopenia in Salisbury, MD
A female patient of nearly 70, diagnosed with osteopenia, began a regimen of bioidentical hormone therapy at Remedy Longevity & Cellular Medicine in Salisbury, MD — including estradiol, progesterone, and testosterone formulations. Over the past year of treatment her bone density score has improved, she is putting on more muscle mass, and she is burning through fat stores.
At a Glance
- Who
- Woman, nearly 70 years old
- What they came in with
- Osteopenia — reduced bone density that precedes osteoporosis
- What their care involved
- Bioidentical hormone therapy: estradiol, progesterone, and testosterone formulations
- How long it took
- One year of treatment
- Where they are now
- Improved bone density score, increased muscle mass, and reduced fat stores
The Full Story, in Our Clinician's Words
I have a female patient who is nearly 70 years old who was diagnosed with osteopenia. We did place her on a regimen of bioidentical hormone therapy, including formulations for estradiol, progesterone, as well as some testosterone therapy for her.
And this patient has had improvements in her bone density score over the past year of her treatment. She is putting on more muscle mass and she is burning through fat stores. And she is very happy with her treatment, and we're excited to see her progress.
This case study describes one patient's experience and results at Remedy Longevity & Cellular Medicine. Every patient is different, and individual results vary. This content is for education only and is not medical advice — please consult a qualified clinician about your own health.
Treatments Involved in This Case
Questions About This Case Study
What is the difference between osteopenia and osteoporosis?
Osteopenia is bone density that is lower than normal but not yet low enough to be osteoporosis. It's an important window for intervention — improving bone density at the osteopenia stage can reduce the risk of progressing to osteoporosis and fractures.
Can hormone therapy improve bone density?
Estrogen, progesterone, and testosterone all play roles in maintaining bone. In this patient's case, a year of bioidentical hormone therapy was accompanied by a measurable improvement in her bone density score, along with more muscle mass and less fat. Individual results depend on labs, dosing, and follow-up monitoring.
Is bioidentical hormone therapy an option near age 70?
Age alone doesn't rule it out. Candidacy is determined by a thorough health history, lab work, and an individualized risk-benefit discussion with a clinician — exactly how this patient's plan was built and monitored.
